Pharmaceuticals by today's price change
How far the share price has moved since the previous close.
Summit Therapeutics leads the 61 pharmaceuticals ranked by today's price change, at +4.03%, ahead of Cogent Biosciences (+2.75%) and Spyre Therapeutics (+2.43%). Figures as of 18 Nov 2026, 15:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Summit Therapeutics+4.03%
- Median
- +0.14%
- Combined market value
- MX$95.07T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Summit TherapeuticsSMMT · Health Care | +4.03% | MX$165.1B | MX$206.42 | 4.03% up | 36% down | ||
| 2 | Cogent BiosciencesCOGT · Health Care | +2.75% | MX$92.6B | MX$532.14 | 2.75% up | 20% down | ||
| 3 | Spyre TherapeuticsSYRE · Health Care | +2.43% | MX$169.7B | MX$1,786.93 | 2.43% up | 286% up | ||
| 4 | ABIVAXABVX · Health Care | +2.19% | MX$136.6B | MX$1,560.24 | 2.19% up | 27% down | ||
| 5 | BioMarin PharmaceuticalBMRN · Health Care | +2.03% | MX$215B | MX$1,110.21 | 2.03% up | 11% up | ||
| 6 | Amneal PharmaceuticalsAMRX · Health Care | +1.80% | MX$139.3B | MX$399.82 | 1.80% up | 83% up | ||
| 7 | Elanco Animal HealthELAN · Health Care | +1.74% | MX$244.5B | MX$489.09 | 1.74% up | 20% up | ||
| 8 | Protagonist TherapeuticsPTGX · Health Care | +1.68% | MX$153.9B | MX$2,357.28 | 1.68% up | 46% up | ||
| 9 | Oruka TherapeuticsORKA · Health Care | +1.49% | MX$123.3B | MX$1,817.89 | 1.49% up | 241% up | ||
| 10 | Arrowhead PharmaceuticalsARWR · Health Care | +1.47% | MX$114.7B | MX$811.22 | 1.47% up | 10% up | ||
| 11 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +1.47% | MX$141B | MX$1,794.65 | 1.47% up | 126% up | ||
| 12 | Dr. Reddy's LaboratoriesRDY · Health Care | +1.39% | MX$232.5B | MX$278.85 | 1.39% up | 5% up | ||
| 13 | Legend BiotechLEGN · Health Care | +1.37% | MX$58.9B | MX$303.68 | 1.37% up | 42% down | ||
| 14 | TG TherapeuticsTGTX · Health Care | +1.26% | MX$178.5B | MX$1,180.87 | 1.26% up | 107% up | ||
| 15 | AlkermesALKS · Health Care | +1.20% | MX$143.7B | MX$855.34 | 1.20% up | 58% up | ||
| 16 | Ligand PharmaceuticalsLGND · Health Care | +1.07% | MX$110.5B | MX$5,522.11 | 1.07% up | 43% up | ||
| 17 | Praxis Precision MedicinesPRAX · Health Care | +1.07% | MX$160.3B | MX$5,733.46 | 1.07% up | 61% up | ||
| 18 | Jazz PharmaceuticalsJAZZ · Health Care | +0.99% | MX$290.2B | MX$4,520.79 | 0.99% up | 37% up | ||
| 19 | BridgeBio PharmaBBIO · Health Care | +0.92% | MX$280.8B | MX$1,441.41 | 0.92% up | 17% up | ||
| 20 | CytokineticsCYTK · Health Care | +0.87% | MX$135B | MX$968.87 | 0.87% up | 20% down | ||
| 21 | Rhythm PharmaceuticalsRYTM · Health Care | +0.78% | MX$151.5B | MX$2,185.45 | 0.78% up | 13% up | ||
| 22 | ViatrisVTRS · Health Care | +0.76% | MX$439.3B | MX$383.18 | 0.76% up | 96% up | ||
| 23 | Vertex PharmaceuticalsVRTX · Health Care | +0.72% | MX$2.54T | MX$10,006.18 | 0.72% up | 27% up | ||
| 24 | Roivant SciencesROIV · Health Care | +0.65% | MX$525B | MX$724.52 | 0.65% up | 90% up | ||
| 25 | Belite BioBLTE · Health Care | +0.57% | MX$119.8B | MX$2,949.67 | 0.57% up | 31% up | ||
| 26 | Dianthus TherapeuticsDNTH · Health Care | +0.52% | MX$91.6B | MX$1,625.98 | 0.52% up | 113% up | ||
| 27 | VeradermicsMANE · Health Care | +0.41% | MX$99B | MX$2,346.14 | 0.41% up | 233% up | ||
| 28 | PTC TherapeuticsPTCT · Health Care | +0.40% | MX$94.1B | MX$1,126.94 | 0.40% up | 20% down | ||
| 29 | Regeneron PharmaceuticalsREGN · Health Care | +0.36% | MX$1.85T | MX$17,875.43 | 0.36% up | 36% up | ||
| 30 | Ionis PharmaceuticalsIONS · Health Care | +0.24% | MX$83.7B | MX$502.57 | 0.24% up | 64% down | ||
| 31 | Definium TherapeuticsDFTX · Health Care | +0.14% | MX$74.9B | MX$547.11 | 0.14% up | 169% up | ||
| 32 | Royalty PharmaRPRX · Health Care | +0.04% | MX$734.7B | MX$1,277.76 | 0.04% up | 78% up | ||
| 33 | Abbott LaboratoriesABT · Health Care | -0.07% | MX$3.37T | MX$1,945.93 | 0.07% down | 17% down | ||
| 34 | ZoetisZTS · Health Care | -0.07% | MX$630.3B | MX$1,551.31 | 0.07% down | 29% down | ||
| 35 | Teva Pharmaceutical IndustriesTEVA · Health Care | -0.19% | MX$923.1B | MX$791.09 | 0.19% down | 74% up | ||
| 36 | SanofiSNY · Health Care | -0.20% | MX$2.12T | MX$882.12 | 0.20% down | 4% down | ||
| 37 | GenmabGMAB · Health Care | -0.31% | MX$594B | MX$963.29 | 0.31% down | 70% up | ||
| 38 | GSKGSK · Health Care | -0.32% | MX$1.83T | MX$912.71 | 0.32% down | 6% up | ||
| 39 | Mirum PharmaceuticalsMIRM · Health Care | -0.34% | MX$111.3B | MX$1,704.18 | 0.34% down | 31% up | ||
| 40 | Ascendis PharmaASND · Health Care | -0.44% | MX$329.4B | MX$5,021.03 | 0.44% down | 28% up | ||
| 41 | InsmedINSM · Health Care | -0.61% | MX$494.1B | MX$2,252.40 | 0.61% down | 40% down | ||
| 42 | GrifolsGRFS · Health Care | -0.64% | MX$108.5B | MX$159.46 | 0.64% down | 1% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | -0.69% | MX$85B | MX$776.40 | 0.69% down | 88% up | ||
| 44 | PfizerPFE · Health Care | -0.69% | MX$3T | MX$525.78 | 0.69% down | 14% up | ||
| 45 | Corcept TherapeuticsCORT · Health Care | -0.78% | MX$141.5B | MX$1,292.82 | 0.78% down | 8% down | ||
| 46 | Takeda PharmaceuticalTAK · Health Care | -0.88% | MX$1.27T | MX$398.89 | 0.88% down | 54% up | ||
| 47 | Johnson & JohnsonJNJ · Health Care | -0.90% | MX$12.36T | MX$5,135.96 | 0.90% down | 38% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -0.93% | MX$180.6B | MX$7,774.42 | 0.93% down | 24% down | ||
| 49 | United TherapeuticsUTHR · Health Care | -1.06% | MX$457.7B | MX$10,747.43 | 1.06% down | 23% up | ||
| 50 | Eli LillyLLY · Health Care | -1.06% | MX$23.2T | MX$26,044.85 | 1.06% down | 35% up | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | -1.12% | MX$131.5B | MX$2,499.82 | 1.12% down | 7% down | ||
| 52 | Alnylam PharmaceuticalsALNY · Health Care | -1.16% | MX$385.3B | MX$2,876.49 | 1.16% down | 66% down | ||
| 53 | AbbVieABBV · Health Care | -1.21% | MX$9.51T | MX$5,379.39 | 1.21% down | 26% up | ||
| 54 | Travere TherapeuticsTVTX · Health Care | -1.21% | MX$90.1B | MX$938.74 | 1.21% down | 44% up | ||
| 55 | NovartisNVS · Health Care | -1.43% | MX$5.51T | MX$2,916.94 | 1.43% down | 25% up | ||
| 56 | AstraZenecaAZN · Health Care | -1.44% | MX$5.18T | MX$3,340.85 | 1.44% down | 2% up | ||
| 57 | Novo NordiskNVO · Health Care | -1.63% | MX$3.28T | MX$744.51 | 1.63% down | 17% down | ||
| 58 | Bristol-Myers SquibbBMY · Health Care | -1.83% | MX$2.29T | MX$1,119.97 | 1.83% down | 34% up | ||
| 59 | Merck & CoMRK · Health Care | -1.89% | MX$6.45T | MX$2,615.87 | 1.89% down | 51% up | ||
| 60 | BeOne MedicinesONC · Health Care | -2.00% | MX$860.3B | MX$7,531.74 | 2.00% down | 17% up | ||
| 61 | ErascaERAS · Health Care | -2.23% | MX$88.6B | MX$252.54 | 2.23% down | 403% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 18.5964 MXN).
Questions and answers
Which pharmaceuticals rank first by today's price change?
Summit Therapeutics (+4.03%), Cogent Biosciences (+2.75%) and Spyre Therapeutics (+2.43%) are the top three of the 61 pharmaceuticals ranked by today's price change as of 18 Nov 2026, 15:16 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by today's price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by today's price change have a combined market value of MX$95.07T as of 18 Nov 2026, 15:16 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.